Clinical trials recruiting for Unresectable Melanoma
11
Recruiting trials
40
US states with sites
17
Countries
0%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 6 |
| Florida | 6 |
| Pennsylvania | 5 |
| Colorado | 4 |
| New York | 4 |
| Illinois | 3 |
| Kentucky | 3 |
| Massachusetts | 3 |
| Ohio | 3 |
| Utah | 3 |
| Wisconsin | 3 |
| Kansas | 2 |
Top cities
Los Angeles, California 5New York, New York 4Aurora, Colorado 3Boston, Massachusetts 3Chicago, Illinois 3Pittsburgh, Pennsylvania 3Salt Lake City, Utah 3Albuquerque, New Mexico 2Cincinnati, Ohio 2City of Saint Peters, Missouri 2
Self-screener
Recruiting trials
- A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
- A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel
- A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
- BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients
- Dual-Target CSPG4/GD2 CAR-NK Cells for Advanced Melanoma
- Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
- Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma
- Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
- Prebiotic Food-enriched Diet (PreFED) to Enhance the Microbiome and Response to First-line Immunotherapy in Unresectable Melanoma
- Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
Related conditions
Trials recruiting for Unresectable Melanoma often also study these conditions. Each links to its own recruiting-trial list.
Melanoma 487Metastatic Melanoma 40Clinical Stage IV Cutaneous Melanoma AJCC v8 13Clinical Stage III Cutaneous Melanoma AJCC v8 7Metastatic Head and Neck Squamous Cell Carcinoma 5Lung cancer 2180Unresectable Triple-Negative Breast Carcinoma 5Unresectable Malignant Solid Neoplasm 8Unresectable Lung Non-Small Cell Carcinoma 5Triple-Negative Breast Carcinoma 10
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Unresectable Melanoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.